Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 Feb;83(2):397–403. doi: 10.1172/JCI113897

Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen.

J E Schweinle 1, P J Hitchcock 1, A J Tenner 1, C H Hammer 1, M M Frank 1, K A Joiner 1
PMCID: PMC303694  PMID: 2492308

Abstract

Strains of Neisseria gonorrhoeae were used to evaluate bactericidal and opsonic properties of McAb 10 directed against the Neisserial outer membrane antigen, H.8. Gonococci were either serum resistant in the absence but serum sensitive in the presence, of McAb 10, or serum sensitive or serum resistant regardless of the presence of McAb 10. Strain JS3, which fell in the former category, was used in subsequent studies. C1 zymogen formed by reassociation of isolated C1 subunits was not directly activated by JS3 in the presence or absence of C1-inhibitor. JS3 thus was unable to directly activate the classical pathway independently of antibody. When purified classical pathway components were used to deposit C3 on JS3 in the absence of serum regulatory proteins or antibodies, added C1-inhibitor reduced C3 binding to background levels. When McAb 10 was present, C3 binding was unaffected by C1-inhibitor. Covalently bound, large molecular weight C3 alpha-chain-gonococcal complexes were disbanded by methylamine release of ester linkages. Released 125I-C3 migrated as C3b without degradation by gonococcal proteases. Purified classical components alone or McAb 10 alone facilitated JS3 killing by neutrophils; when combined, the two provided maximal killing. Levels of McAb 10 that only slightly increase C3 deposition on JS3 are bactericidal in serum and maximally opsonic in combination with purified classical pathway components.

Full text

PDF
397

Images in this article

401Image
on p.401

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aho E. L., Murphy G. L., Cannon J. G. Distribution of specific DNA sequences among pathogenic and commensal Neisseria species. Infect Immun. 1987 Apr;55(4):1009–1013. doi: 10.1128/iai.55.4.1009-1013.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Apicella M. A. Serogrouping of Neisseria gonorrhoeae: identification of four immunologically distinct acidic polysaccharides. J Infect Dis. 1976 Oct;134(4):377–383. doi: 10.1093/infdis/134.4.377. [DOI] [PubMed] [Google Scholar]
  3. Aubert B., Chesne S., Arlaud G. J., Colomb M. G. Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4. Biochem J. 1985 Dec 1;232(2):513–519. doi: 10.1042/bj2320513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bartholomew R. M., Esser A. F. Mechanism of antibody-independent activation of the first component of complement (Cl) on retrovirus membranes. Biochemistry. 1980 Jun 24;19(13):2847–2853. doi: 10.1021/bi00554a005. [DOI] [PubMed] [Google Scholar]
  5. Betz S. J., Isliker H. Antibody-independent interactions between Escherichia coli J5 and human complement components. J Immunol. 1981 Nov;127(5):1748–1754. [PubMed] [Google Scholar]
  6. Black J. R., Black W. J., Cannon J. G. Neisserial antigen H.8 is immunogenic in patients with disseminated gonococcal and meningococcal infections. J Infect Dis. 1985 Apr;151(4):650–657. doi: 10.1093/infdis/151.4.650. [DOI] [PubMed] [Google Scholar]
  7. Cannon J. G., Black W. J., Nachamkin I., Stewart P. W. Monoclonal antibody that recognizes an outer membrane antigen common to the pathogenic Neisseria species but not to most nonpathogenic Neisseria species. Infect Immun. 1984 Mar;43(3):994–999. doi: 10.1128/iai.43.3.994-999.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clas F., Loos M. Antibody-independent binding of the first component of complement (C1) and its subcomponent C1q to the S and R forms of Salmonella minnesota. Infect Immun. 1981 Mar;31(3):1138–1144. doi: 10.1128/iai.31.3.1138-1144.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Colomb M. G., Arlaud G. J., Villiers C. L. Structure and activation of C1: current concepts. Complement. 1984;1(2):69–80. doi: 10.1159/000467818. [DOI] [PubMed] [Google Scholar]
  10. Cooper N. R. The classical complement pathway: activation and regulation of the first complement component. Adv Immunol. 1985;37:151–216. doi: 10.1016/s0065-2776(08)60340-5. [DOI] [PubMed] [Google Scholar]
  11. Cooper N. R., Ziccardi R. J. Reconstitution of C1 in native proenzyme form and its use in a quantitative C1 activation test. J Immunol. 1977 Nov;119(5):1664–1667. [PubMed] [Google Scholar]
  12. Fischer S. H., Rest R. F. Gonococci possessing only certain P.II outer membrane proteins interact with human neutrophils. Infect Immun. 1988 Jun;56(6):1574–1579. doi: 10.1128/iai.56.6.1574-1579.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gotschlich E. C., Blake M. S., Koomey J. M., Seiff M., Derman A. Cloning of the structural genes of three H8 antigens and of protein III of Neisseria gonorrhoeae. J Exp Med. 1986 Sep 1;164(3):868–881. doi: 10.1084/jem.164.3.868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hammer C. H., Wirtz G. H., Renfer L., Gresham H. D., Tack B. F. Large scale isolation of functionally active components of the human complement system. J Biol Chem. 1981 Apr 25;256(8):3995–4006. [PubMed] [Google Scholar]
  15. Harriman G. R., Podack E. R., Braude A. I., Corbeil L. C., Esser A. F., Curd J. G. Activation of complement by serum-resistant Neisseria gonorrhoeae. Assembly of the membrane attack complex without subsequent cell death. J Exp Med. 1982 Oct 1;156(4):1235–1249. doi: 10.1084/jem.156.4.1235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hitchcock P. J., Hayes S. F., Mayer L. W., Shafer W. M., Tessier S. L. Analyses of gonococcal H8 antigen. Surface location, inter- and intrastrain electrophoretic heterogeneity, and unusual two-dimensional electrophoretic characteristics. J Exp Med. 1985 Dec 1;162(6):2017–2034. doi: 10.1084/jem.162.6.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ingwer I., Petersen B. H., Brooks G. Serum bactericidal action and activation of the classic and alternate complement pathways by Neisseria gonorrhoeae. J Lab Clin Med. 1978 Aug;92(2):211–220. [PubMed] [Google Scholar]
  18. Joiner K. A., Scales R., Warren K. A., Frank M. M., Rice P. A. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. J Clin Invest. 1985 Nov;76(5):1765–1772. doi: 10.1172/JCI112167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Joiner K. A., Warren K. A., Brown E. J., Swanson J., Frank M. M. Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae. J Immunol. 1983 Sep;131(3):1443–1451. [PubMed] [Google Scholar]
  20. Joiner K. A., Warren K. A., Hammer C., Frank M. M. Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae. J Immunol. 1985 Mar;134(3):1920–1925. [PubMed] [Google Scholar]
  21. Joiner K. A., Warren K. A., Tam M., Frank M. M. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity. J Immunol. 1985 May;134(5):3411–3419. [PubMed] [Google Scholar]
  22. Judd R. C. Surface peptide mapping of protein I and protein III of four strains of Neisseria gonorrhoeae. Infect Immun. 1982 Aug;37(2):632–641. doi: 10.1128/iai.37.2.632-641.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kawula T. H., Spinola S. M., Klapper D. G., Cannon J. G. Localization of a conserved epitope and an azurin-like domain in the H.8 protein of pathogenic Neisseria. Mol Microbiol. 1987 Sep;1(2):179–185. doi: 10.1111/j.1365-2958.1987.tb00510.x. [DOI] [PubMed] [Google Scholar]
  24. Kovacsovics T., Tschopp J., Kress A., Isliker H. Antibody-independent activation of C1, the first component of complement, by cardiolipin. J Immunol. 1985 Oct;135(4):2695–2700. [PubMed] [Google Scholar]
  25. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  26. Mandrell R., Schneider H., Apicella M., Zollinger W., Rice P. A., Griffiss J. M. Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharides. Infect Immun. 1986 Oct;54(1):63–69. doi: 10.1128/iai.54.1.63-69.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Peitsch M. C., Kovacsovics T. J., Tschopp J., Isliker H. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement. J Immunol. 1987 Mar 15;138(6):1871–1876. [PubMed] [Google Scholar]
  28. Prograis L. J., Jr, Hammer C. H., Katusha K., Frank M. M. Purification of C1 inhibitor. A new approach for the isolation of this biologically important plasma protease inhibitor. J Immunol Methods. 1987 May 4;99(1):113–122. doi: 10.1016/0022-1759(87)90039-1. [DOI] [PubMed] [Google Scholar]
  29. Schoolnik G. K., Ochs H. D., Buchanan T. M. Immunoglobulin class responsible for gonococcal bactericidal activity of normal human sera. J Immunol. 1979 May;122(5):1771–1779. [PubMed] [Google Scholar]
  30. Shafer W. M., Joiner K., Guymon L. F., Cohen M. S., Sparling P. F. Serum sensitivity of Neisseria gonorrhoeae: the role of lipopolysaccharide. J Infect Dis. 1984 Feb;149(2):175–183. doi: 10.1093/infdis/149.2.175. [DOI] [PubMed] [Google Scholar]
  31. Strittmatter W., Hitchcock P. J. Isolation and preliminary biochemical characterization of the gonococcal H.8 antigen. J Exp Med. 1986 Dec 1;164(6):2038–2048. doi: 10.1084/jem.164.6.2038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Swanson J., Mayer L. W., Tam M. R. Antigenicity of Neisseria gonorrhoeae outer membrane protein(s) III detected by immunoprecipitation and Western blot transfer with a monoclonal antibody. Infect Immun. 1982 Nov;38(2):668–672. doi: 10.1128/iai.38.2.668-672.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Swanson J. Studies on gonococcus infection. XII. Colony color and opacity varienats of gonococci. Infect Immun. 1978 Jan;19(1):320–331. doi: 10.1128/iai.19.1.320-331.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Swanson J. Surface-exposed protein antigens of the gonococcal outer membrane. Infect Immun. 1981 Dec;34(3):804–816. doi: 10.1128/iai.34.3.804-816.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tenner A. J., Frank M. M. Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1. J Immunol. 1986 Jul 15;137(2):625–630. [PubMed] [Google Scholar]
  36. Tenner A. J., Lesavre P. H., Cooper N. R. Purification and radiolabeling of human C1q. J Immunol. 1981 Aug;127(2):648–653. [PubMed] [Google Scholar]
  37. Tenner A. J., Ziccardi R. J., Cooper N. R. Antibody-independent C1 activation by E. coli. J Immunol. 1984 Aug;133(2):886–891. [PubMed] [Google Scholar]
  38. Tramont E. C., Sadoff J. C., Wilson C. Variability of the lytic susceptibility of Neisseria gonorrhoeae to human sera. J Immunol. 1977 May;118(5):1843–1851. [PubMed] [Google Scholar]
  39. Valet G., Cooper N. R. Isolation and characterization of the proenzyme form of the C1s subunit of the first complement component. J Immunol. 1974 Jan;112(1):339–350. [PubMed] [Google Scholar]
  40. Virji M., Heckels J. E. The effect of protein II and pili on the interaction of Neisseria gonorrhoeae with human polymorphonuclear leucocytes. J Gen Microbiol. 1986 Feb;132(2):503–512. doi: 10.1099/00221287-132-2-503. [DOI] [PubMed] [Google Scholar]
  41. Vukajlovich S. W. Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A. Infect Immun. 1986 Sep;53(3):480–485. doi: 10.1128/iai.53.3.480-485.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Vukajlovich S. W., Hoffman J., Morrison D. C. Activation of human serum complement by bacterial lipopolysaccharides: structural requirements for antibody independent activation of the classical and alternative pathways. Mol Immunol. 1987 Apr;24(4):319–331. doi: 10.1016/0161-5890(87)90173-8. [DOI] [PubMed] [Google Scholar]
  43. Ziccardi R. J. A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement. J Immunol. 1982 Jun;128(6):2505–2508. [PubMed] [Google Scholar]
  44. Ziccardi R. J., Cooper N. R. Physicochemical and functional characterization of the C1r subunit of the first complement component. J Immunol. 1976 Feb;116(2):496–503. [PubMed] [Google Scholar]
  45. Ziccardi R. J. Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism. J Immunol. 1982 Jun;128(6):2500–2504. [PubMed] [Google Scholar]
  46. Ziccardi R. J. The first component of human complement (C1): activation and control. Springer Semin Immunopathol. 1983;6(2-3):213–230. doi: 10.1007/BF00205874. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES